Meds A-Z
Triamcinolone Acetonide
Detailed information about Triamcinolone Acetonide
Official label facts
Owner quick guide first
Marketing clearly labeled
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Add to My Pet's Meds
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueReviewed / Updated / Sources
Reviewed: Not available
Updated: February 12, 2026, 10:44 PM UTC
Sources:
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Medalone Cream · official_label
- openFDA case USA-USFDACVM-2025-US-046437 · adverse_reaction
Pet Owner Quick Guide
Start here first for the simple next-step summary.
Used for:
For cystic areas. Use petrolatum base ointment for the treatment interdigital cysts.
What to watch for:
- Do not use in viral infections
- With bacterial infections appropriate antibacterial therapy should be used
- Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy
- Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis
- Do not use in horses intended for human consumption
- Do not use in the treatment of laminitis
- Intra-articular injection in equine leg injuries may produce osseous metaplasia
- For mild inflammations, use once daily to once a week
- For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs
- Not intended for treatment of deep abscesses or deep-seated infections
- Not for ophthalmic use
- Vomiting (1 reports)
- very low energy (1 reports)
- Neurological symptoms NOS (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
Regulatory restrictions are shown in Vet View.
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Safety & side effects
What to watch:
- Do not use in viral infections
- With bacterial infections appropriate antibacterial therapy should be used
- Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy
- Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis
- Do not use in horses intended for human consumption
Most reported reactions:
- Vomiting (1 reports)
- Tiredness (lethargy) (1 reports)
- Neurological symptoms NOS (1 reports)
When to call your vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Data freshness: source data appears current.
Latest refresh: Mar 21, 2026, 10:01 a.m.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 11, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:21 AM UTC
Image coming soon
Triamcinolone Acetonide
Triamcinolone Acetonide
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Zoetis Inc.
Form: Cream, Liquid (Solution), Liquid (Suspension), Ointment, Powder, Tablet
Identifiers:
ANADA: 200245
ANADA: 200275
ANADA: 200330
ANADA: 200459
NADA: 12198
NADA: 12258
NADA: 13624
NADA: 137694
NADA: 138869
NADA: 140810
NADA: 140847
NADA: 140879
NADA: 140889
NADA: 141003
NADA: 141210
NADA: 30045
NADA: 46146
NADA: 96676
NADA: 99388
NDC Package: 17033-122-15
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/140810 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200245 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- High: Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
32
Serious reports
21
Species represented
2
Grouped by Body System
Digestive (5)
· Vomiting, Nausea, Drooling
Skin & allergy (1)
· Localised hair loss
Neurologic (3)
· Tiredness (lethargy), Neurological symptoms NOS, Head tilt - neurological disorder
Behavior (2)
· Head shake - behavioural disorder, Behavioral disorder (unspecified)
Effectiveness (1)
· Lack of efficacy - NOS
Other (20)
· Not himself/herself, Not eating, Mouth pain
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Digestive | 1 | Dog | 1 | |
| Neurologic | 1 | Cat | 1 | |
| Neurologic | 1 | Cat | 1 | |
| Digestive | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (16) Cat (16)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Digestive | Dog | Serious | - | 1 | |
| Neurologic | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Neurologic | Cat | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Skin & allergy | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Effectiveness | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Neurologic | Cat | Non-serious | - | 1 | |
| Behavior | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Behavior | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-046437
Documents
Owner handouts and official technical documents are grouped for faster access.
Owner handouts (0)
- No owner handouts linked yet.
Official label / PI (0)
- No official label or package insert links yet.
SPL (19)
-
DERMA-VET® Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1443/DERMA-VET%C2%AE%20Ointment
-
Derma-Vet Cream
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/96/Derma-Vet%20Cream
-
Medalone Cream
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1358/Medalone%20Cream
-
Triamcinolone Acetonide
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1681/Triamcinolone%20Acetonide
-
Vetalog Cream
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/838/Vetalog%20Cream
-
Vetalog Oral Powder
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1884/Vetalog%20Oral%20Powder
-
Triamcinolone Acetonide Suspension
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1451/Triamcinolone%20Acetonide%20Suspension
-
Vetalog® Parenteral
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/702/Vetalog%C2%AE%20Parenteral
-
Animax® Cream
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/110/Animax%C2%AE%20Cream
-
Animax® Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2491/Animax%C2%AE%20Ointment
-
Derma 4 Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1429/Derma%204%20Ointment
-
Vetalog®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2501/Vetalog%C2%AE
-
VETAZINE
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2576/VETAZINE
-
Derm-Otic Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1855/Derm-Otic%20Ointment
-
Derm-Otic Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1382/Derm-Otic%20Ointment
-
Genesis® Topical Spray
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/460/Genesis%C2%AE%20Topical%20Spray
-
Neo-Aristovet Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1719/Neo-Aristovet%20Ointment
-
Panolog® Cream
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2535/Panolog%C2%AE%20Cream
-
Panolog® Ointment
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/706/Panolog%C2%AE%20Ointment
FOI (8)
-
N140810_Org_5_31_1988.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1362
-
ucm061671.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/971
-
ucm061703.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1032
-
N138869_Org_1_6_1987..pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/2551
-
ucm061795.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1079
-
N140847_Org_9_30_1988.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1363
-
N140879_Org_8_2_1989.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1366
-
ucm117775.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/734
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1362 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1443/DERMA-VET%C2%AE%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/971 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/96/Derma-Vet%20Cream · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1032 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1358/Medalone%20Cream · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1681/Triamcinolone%20Acetonide · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/838/Vetalog%20Cream · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1884/Vetalog%20Oral%20Powder · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/2551 · document · FOI
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 11, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:21 AM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
Animax® Cream
Animax® Ointment
DERMA-VET® Ointment
Derm-Otic Ointment
Derma 4 Ointment
Derma-Vet Cream
Genesis® Topical Spray
Medalone Cream
Neo-Aristovet Ointment
Panolog® Cream
Panolog® Ointment
Triamcinolone Acetonide
Triamcinolone Acetonide Suspension
VETAZINE
Vetalog Cream
Vetalog Oral Powder
Vetalog®
Vetalog® Parenteral
Case-reported brands (openFDA):
MSK
Catalog species: Both
•
FDA-labeled species: Cat, Dog, Horse, No Use Class Stated Or Implied
Rx/OTC: RX
Form/route:
Cream, Liquid (Solution), Liquid (Suspension), Ointment, Powder, Tablet
• Intra-Articular, Intralesional, Intramuscular, Intrasynovial, Oral, Subcutaneous, Topical
Applications: NADA 140-810 • ANADA 200-245 • ANADA 200-275 • NADA 13624 • NADA 46146 • NADA 99388 • NADA 138-869 • NADA 12198 • ANADA 200-330 • NADA 140-847 • NADA 140-879 • NADA 137-694 • ANADA 200-459 • NADA 140-889 • NADA 141-003 • NADA 141-210 • NADA 30045 • NADA 96676 • NADA 12258
Explore
Related conditions:
Abscesses (cat bite abscess)
Dystocia
Metritis
Pica
Pruritus (itching, undifferentiated)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Vomiting (1)
Tiredness (lethargy) (1)
Neurological symptoms NOS (1)
Nausea (1)
Mouth pain (1)
Miosis (1)
Medication error NOS (1)
Incorrect route of drug administration (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
ANADA: 200245
ANADA: 200275
ANADA: 200330
ANADA: 200459
NADA: 12198
NADA: 12258
NADA: 13624
NADA: 137694
NADA: 138869
NADA: 140810
NADA: 140847
NADA: 140879
NADA: 140889
NADA: 141003
NADA: 141210
NADA: 30045
NADA: 46146
NADA: 96676
NADA: 99388
NDC Package: 17033-122-15
NDC Package: 17033-122-30
NDC Package: 17033-122-75
NDC Package: 51311-105-08
NDC Package: 51311-105-16
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 17033-122-15 | 17033 | - | |
| 17033-122-30 | 17033 | - | |
| 17033-122-75 | 17033 | - | |
| 51311-105-08 | 51311 | - | |
| 51311-105-16 | 51311 | - | |
| 73309-105-01 | 73309 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
N140810_Org_5_31_1988.pdf
• FOI summary • Official
• Jan. 21, 2025
FDA FOI summary for application 140810
-
ucm061703.pdf
• FOI summary • Official
• Dec. 26, 2023
FDA FOI summary for application 200275
-
ucm061671.pdf
• FOI summary • Official
• Dec. 26, 2023
FDA FOI summary for application 200245
-
N138869_Org_1_6_1987..pdf
• FOI summary • Official
• Feb. 1, 2018
FDA FOI summary for application 138869
-
ucm061795.pdf
• FOI summary • Official
• Dec. 27, 2017
FDA FOI summary for application 200330
-
N140879_Org_8_2_1989.pdf
• FOI summary • Official
• May 17, 2017
FDA FOI summary for application 140879
-
N140847_Org_9_30_1988.pdf
• FOI summary • Official
• May 17, 2017
FDA FOI summary for application 140847
-
ucm117775.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141210
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 11
Clinical 0
Manufacturer 0
Marketing 0
Current Field Facts
- contraindications: Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic ne… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Deafness, Loss of hearing, Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Lack of efficac… (Official, 2026-02-12)
- usage: Treatment of inflammation and related disorders in dogs; and management and treatment of acute arthritis and allergic and dermatologic disorders in dogs. Treat… (Official, 2026-02-12)
Recent Revisions
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
DERMA-VET® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Med-Pharmex, Inc. | NADA 140-810 | W | Jan 21, 2025 |
|
Derma-Vet Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream
• Topical
|
Med-Pharmex, Inc. | ANADA 200-245 | W | Dec 26, 2023 |
|
Medalone Cream
RX
Triamcinolone Acetonide
Cream
• Topical
|
Med-Pharmex, Inc. | ANADA 200-275 | W | Dec 26, 2023 |
|
Triamcinolone Acetonide
RX
Triamcinolone Acetonide
Tablet
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 13624 | W | May 3, 2023 |
|
Vetalog Cream
RX
Triamcinolone Acetonide
Cream
• Topical
|
Boehringer lngelheim Animal Health USA Inc. | NADA 46146 | W | May 3, 2023 |
|
Vetalog Oral Powder
RX
Triamcinolone Acetonide
Powder
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 99388 | W | May 3, 2023 |
|
Triamcinolone Acetonide Suspension
RX
Triamcinolone Acetonide
Liquid (Suspension)
• Intramuscular, Intra-Articular, Intrasynovial, Subcutaneous, Intralesional
|
Cronus Pharma Specialities India Private Ltd. | NADA 138-869 | Approved | Feb 1, 2018 |
|
Vetalog® Parenteral
RX
Triamcinolone Acetonide
Liquid (Suspension)
• Intramuscular, Intralesional, Intra-Articular, Subcutaneous, Intrasynovial
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 12198 | Approved | Jan 9, 2018 |
|
Animax® Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream
• Topical
|
Fougera Pharmaceuticals, Inc. | ANADA 200-330 | Approved | Dec 27, 2017 |
|
Animax® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Fougera Pharmaceuticals, Inc. | NADA 140-847 | Approved | May 17, 2017 |
|
Derma 4 Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Zoetis Inc. | NADA 140-879 | Approved | May 17, 2017 |
|
Vetalog®
RX
Triamcinolone Acetonide
Tablet
• Oral
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 137-694 | Approved | Feb 23, 2017 |
|
VETAZINE
Triamcinolone Acetonide
Cream
• Topical
|
Modern Veterinary Therapeutics, LLC | ANADA 200-459 | W | Aug 16, 2016 |
|
Derm-Otic Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Biocraft Laboratories, Inc. | NADA 140-889 | W | Jun 1, 2016 |
|
Derm-Otic Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Zoetis Inc. | NADA 141-003 | Approved | Jun 1, 2016 |
|
Genesis® Topical Spray
RX
Triamcinolone Acetonide
Liquid (Solution)
• Topical
|
Virbac AH, Inc. | NADA 141-210 | Approved | Jun 1, 2016 |
|
Neo-Aristovet Ointment
RX
Neomycin Sulfate Triamcinolone Acetonide
|
Bayer HealthCare LLC, Animal Health Division | NADA 30045 | W | Jun 1, 2016 |
|
Panolog® Cream
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Cream
• Topical
|
Zoetis Inc. | NADA 96676 | Approved | Jun 1, 2016 |
|
Panolog® Ointment
RX
Neomycin Sulfate Nystatin Thiostrepton Triamcinolone Acetonide
Ointment
• Topical
|
Zoetis Inc. | NADA 12258 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment interdigital cysts.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment in for the treatment interdigital cysts and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Triamcinolone acetonide cream contains 0.1 percent triamcinolone acetonide in an aqueous vanishing cream base.
Dogs
Indication
The drug is recommended for use on dogs as an anti-inflammatory, antipruritic, and antiallergic agent for topical treatment of allergic dermatitis and summer eczema.
Dosage
The drug is applied by rubbing into affected areas two to four times daily for 4 to 10 days.
Limitations
For use only by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 0.5 and 1.5 milligrams of the drug.
Dogs
Indication
The drug is indicated for use in dogs for its anti-inflammatory activity.
Dosage
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day. Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear.
Limitations
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated for use in cats for its anti-inflammatory activity.
Dosage
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day. Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear.
Limitations
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Triamcinolone acetonide cream contains 0.1 percent triamcinolone acetonide in an aqueous vanishing cream base.
Dogs
Indication
The drug is recommended for use on dogs as an anti-inflammatory, antipruritic, and antiallergic agent for topical treatment of allergic dermatitis and summer eczema.
Dosage
The drug is applied by rubbing into affected areas two to four times daily for 4 to 10 days.
Limitations
For use only by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, Not For Meat Production
Composition / specifications
Each 15 grams of triamcinolone acetonide oral powder contains 10 milligrams of triamcinolone acetonide.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
It is administered at a dosage of 0.005 to 0.01 milligram triamcinolone acetonide per pound of body weight twice daily, sprinkled (top-dressed) on a small portion of feed. Treatment may be initiated with a single dose of sterile triamcinolone acetonide suspension USP followed after 3 or 4 days with the use of triamcinolone acetonide oral powder.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, Restricted During Pregnancy • Horse, Not For Meat Production • Cat, Restricted During Pregnancy
Composition / specifications
Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide.
Horses
Indication
Treatment of inflammation and related disorders.
Dosage
Single injection of 0.01 to 0.02 milligrams intramuscularly or subcutaneously per pound of body weight. Usual dose, 12 to 20 milligrams intramuscularly or subcutaneously. Or administer single injection of 6 to 18 milligrams intra-articularly and intrasynovially dose dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage may be increased not to exceed 18 milligrams intra-articularly and intrasynovially.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Not for use in horses intended for food. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
Treatment of inflammation and related disorders and management and treatment of acute arthritis and allergic and dermatologic disorders.
Dosage
Single injection of 0.05 to 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Or administer 1.2 to 1.8 milligrams intralesionally, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams intralesionally and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams intralesionally. Or administer a single injection of 1 to 3 milligrams intra-articularly and intrasynovially, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams intra-articularly and intrasynovially.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Treatment of inflammation and related disorders and management and treatment of acute arthritis and allergic and dermatologic disorders.
Dosage
Single injection of 0.05 to 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Or administer 1.2 to 1.8 milligrams intralesionally, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams intralesionally and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams intralesionally. Or administer a single injection of 1 to 3 milligrams intra-articularly and intrasynovially, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams intra-articularly and intrasynovially.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, Restricted During Pregnancy • No Use Class Stated Or Implied • Cat, Restricted During Pregnancy
Composition / specifications
Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide.
Dogs
Indication
Treatment of inflammation and related disorders in dogs; and management and treatment of acute arthritis and allergic and dermatologic disorders in dogs.
Dosage
Intramuscular or subcutaneous: Single injection of 0.05 to 0.1 milligram per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligram per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted.
Intralesional: 1.2 to 1.8 milligrams, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams.
Intra-articular and intrasynovial: Single injection of 1 to 3 milligram dose, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
Treatment of inflammation and related disorders in horses.
Dosage
Intramuscular or subcutaneous: Single injection of 0.01 to 0.02 milligrams per pound of body weight. Usual dose, 12 to 20 milligrams.
Intra-articular and intrasynovial: Single injection of 6 to 18 milligram dose dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage may be increased not to exceed 18 milligrams.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental da
Indication
Treatment of inflammation and related disorders in cats; and management and treatment of acute arthritis and allergic and dermatologic disorders in cats.
Dosage
Intramuscular or subcutaneous: Single injection of 0.05 to 0.1 milligram per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligram per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted.
Intralesional: 1.2 to 1.8 milligrams, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams.
Intra-articular and intrasynovial: Single injection of 1 to 3 milligram dose, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams.
Limitations
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
For mild inflammations, application may range from once daily to once a week; for severe
conditions Animax Ointment may be applied as often as two to three times daily, if necessary.
Frequency of treatment may be decreased as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts, and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 0.5 and 1.5 milligrams of the drug.
Cats
Indication
The drug is indicated for anti-inflammatory activity.
Dosage
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day.
Limitations
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated for anti-inflammatory activity.
Dosage
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day.
Limitations
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
1 mg of triamcinolone acetonide per gram
Dogs
Indication
For topical treatment of allergic dermatitis and summer eczema in dogs.
Dosage
Apply by rubbing into the affected areas two to four times daily for 4 to 10 days.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts, and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Dosage
Drain cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian
Dogs
Indication
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Dosage
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Dosage
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Limitations
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 0.15 milligrams (0.015%) triamcinolone acetonide.
Dogs
Indication
For the control of pruritus associated with allergic dermatitis.
Dosage
Apply sufficient pump sprays to uniformly and thoroughly wet the affected areas while avoiding run off of excess product. Administer twice daily for 7 days, then once daily for 7 days, then every other day for an additional 14 days (28 days total).
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For topical use in dogs only.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.
Cats
Indication
Otitis and cysts: Use petrolatum base ointment in cats for the treatment of acute and chronic otitis and interdigital cysts.
Dosage
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
Topically: Use either ointment in cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
Otitis, cysts, and anal gland infections: Use petrolatum base ointment in dogs for the treatment of acute and chronic otitis and interdigital cysts, and in dogs for anal gland infections.
Dosage
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable.
For infected anal glands and cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indication
Topically: Use either ointment in dogs for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Dosage
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Limitations
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
Documents
-
Summary
Panavet Ointment (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment) is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs, and in anal gland infections in dogs.Â
The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis, and as an adjunct in the treatment of dermatitis due to parasitic infestation.
SPL Packages
- DERMA-VET® Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061671.pdf
Summary
Derma-Vet Cream is indicated in the management of dermatologic disorders in dogs and cats, characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis and seborrheic dermatitis; and as an adjunct in the treatment of dermatitis due to parasitic infestation.
SPL Packages
- Derma-Vet Cream (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061703.pdf
Summary
Medalone Cream (Triamcinolone Acetonide Cream) is indicated for topical treatment of allergic dermatitis and summer eczema in dogs.
SPL Packages
- Medalone Cream (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Triamcinolone Acetonide (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Vetalog Cream (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Vetalog Oral Powder (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
Triamcinolone acetonide is a highly potent glucocorticoid effective in the treatment of inflammation and related disorders in dogs, cats and horses. It is also indicated for use in the management and treatment of acute arthritis and allergic and dermatologic disorders in dogs and cats.
The product is recommended for intramuscular, subcutaneous, intra-articular and intrasynovial injection in dogs, cats and horses and intralesional injection in dogs and cats.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Vetalog® Parenteral (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061795.pdf
Summary
Topical dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal infections.
SPL Packages
- Animax® Cream (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
Animax Ointment (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment) is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs, and in anal gland infections in dogs.Â
The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis, and as an adjunct in the treatment of dermatitis due to parasitic infestation.Â
SPL Packages
- Animax® Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
DERMA 4 Ointment is particularly useful in the treatment of:
- Â acute and chronic otitis of varied etiologies;
- interdigital cysts in dogs and cat;
- anal gland infections in dogs;
- dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infection; and
- eczematous, contact and seborrheic dermatitis.
Additionally, DERMA 4 Ointment may be used as an adjunct in the treatment of dermatitis due to parasitic infestation.
SPL Packages
- Derma 4 Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Vetalog® (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- VETAZINE (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Derm-Otic Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Derm-Otic Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm117775.pdf
Summary
For the control of pruritus associated with allegic dermatitis in dogs.
SPL Packages
- Genesis® Topical Spray (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Neo-Aristovet Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Panolog® Cream (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Panolog® Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
Treatment of inflammation and related disorders in dogs; and management and treatment of acute arthritis and allergic and dermatologic disorders in dogs. Treatment of inflammation and related disorders in horses. Treatment of inflammation and related disorders in cats; and management and treatment of acute arthritis and allergic and dermatologic disorders in cats.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Vomiting (1)
• Dog
Nausea (1)
• Dog
Drooling (1)
• Dog
Diarrhea (1)
• Cat
Appetite loss (1)
• Dog
Showing top 5 for Digestive.
Skin & allergy
Localised hair loss (1)
• Dog
Showing top 5 for Skin & allergy.
Neurologic
Tiredness (1)
• Cat
Neurological symptoms NOS (1)
• Cat
Head tilt - neurological disorder (1)
• Cat
Showing top 5 for Neurologic.
Behavior
Head shake - behavioural disorder (1)
• Cat
Behavioral disorder (1)
• Cat
Showing top 5 for Behavior.
Effectiveness
Lack of efficacy - NOS (1)
• Dog
Showing top 5 for Effectiveness.
Other
Not himself/herself (1)
• Cat
Not eating (1)
• Cat
Mouth pain (1)
• Cat
Moist dermatitis (1)
• Dog
Miosis (1)
• Cat
Show more (15)
Medication error NOS (1)
• Dog
Licking at application site (1)
• Dog
Incorrect route of drug administration (1)
• Dog
Inappropriate urination (1)
• Dog
Hiding (1)
• Cat
Eye disorder NOS (1)
• Cat
Eardrum rupture (1)
• Cat
Ear infection NOS (1)
• Dog
Ear discharge (1)
• Cat
Dry skin (1)
• Dog
Deafness (1)
• Dog
Blindness (1)
• Cat
Application site scratching (1)
• Dog
Accidental exposure (1)
• Dog
Abnormal breathing (1)
• Cat
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Spaniel - King Charles Cavalier, Male, 13.5 year, 14.2 kilogram • Drug: MSK, Ointment • Reactions: Deafness • Outcome: Recovered with Sequela
- Report ID: USA-USFDACVM-2025-US-054270
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 13.50 Year
- Weight: 14.200 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Form: Ointment
Reactions Reported:
Deafness
Outcomes: Recovered with Sequela
Dog, Terrier - Bull, Female, 11 year, 36.9 kilogram • Drug: MSK, Ointment • Reactions: Inappropriate urination, Dry skin, Skin irritation, Reddening of the skin, Skin lesion NOS… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054304
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 11.00 Year
- Weight: 36.900 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Form: Ointment
Reactions Reported:
Inappropriate urination
Dry skin
Skin irritation
Reddening of the skin
Skin lesion NOS
Moist dermatitis
Localised hair loss
Ear discharge
Ear infection NOS
Lack of efficacy - NOS
Outcomes: Outcome Unknown
Dog, Retriever - Golden, Female, 4.5 year, 19.8 kilogram • Drug: MSK, Ointment, Oral • Reactions: Medication error NOS, Nausea, Drooling, Vomiting, Incorrect route of drug administration… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054083
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 4.50 Year
- Weight: 19.800 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Ointment
Reactions Reported:
Medication error NOS
Nausea
Drooling
Vomiting
Incorrect route of drug administration
Accidental exposure
Outcomes: Ongoing
Dog, Spaniel (unspecified), Male, 7 year, 9.6 kilogram • Drug: MSK, Ointment • Reactions: Watery diarrhoea, Medication error NOS, Application site scratching • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054232
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 7.00 Year
- Weight: 9.600 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Form: Ointment
Reactions Reported:
Watery diarrhoea
Medication error NOS
Application site scratching
Outcomes: Outcome Unknown
Dog, ['Shih Tzu', 'Poodle (unspecified)'], Female, 11 year, 4.9 kilogram • Drug: MSK, Ointment, Topical • Reactions: Licking at application site, Appetite loss • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054090
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 11.00 Year
- Weight: 4.900 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Ointment
Reactions Reported:
Licking at application site
Appetite loss
Outcomes: Outcome Unknown
Cat, Domestic Longhair, Female, 10 year, 5.9 kilogram • Drug: MSK, Ointment, Topical • Reactions: Vomiting, Not eating, Licking at application site, Not himself/herself • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-047710
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 10.00 Year
- Weight: 5.900 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Ointment
Reactions Reported:
Vomiting
Not eating
Licking at application site
Not himself/herself
Outcomes: Recovered/Normal
Cat, Domestic Shorthair, Male, 3 year, 3.6 kilogram • Drug: MSK, Ointment, Auricular (Otic) • Reactions: Third eyelid prolapse, Hiding, Tiredness (lethargy), Not eating, Mouth pain… • Outcome: Recovered with Sequela
- Report ID: USA-USFDACVM-2025-US-043229
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Year
- Weight: 3.600 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Ointment
Reactions Reported:
Third eyelid prolapse
Hiding
Tiredness (lethargy)
Not eating
Mouth pain
Head shake - behavioural disorder
Sneezing
Abnormal breathing
Sleepiness - systemic disorder
Ear discharge
Miosis
Eye disorder NOS
Neurological symptoms NOS
Tympanic rupture
Outcomes: Recovered with Sequela
Cat, Domestic Shorthair, Male, 3 year, 3.6 kilogram • Drug: MSK, Gel • Reactions: Tiredness (lethargy), Sneezing, Neurological symptoms NOS, Eye disorder NOS, Miosis… • Outcome: Recovered with Sequela
- Report ID: USA-USFDACVM-2025-US-046437
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 3.00 Year
- Weight: 3.600 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Form: Gel
Reactions Reported:
Tiredness (lethargy)
Sneezing
Neurological symptoms NOS
Eye disorder NOS
Miosis
Ear discharge
Sleepiness - systemic disorder
Abnormal breathing
Head shake - behavioural disorder
Mouth pain
Not eating
Blindness
Eardrum rupture
Outcomes: Recovered with Sequela
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.